These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 26169945)
1. Icariin reduces α-synuclein over-expression by promoting α-synuclein degradation. Zhang L; Shen C; Chu J; Liu Y; Li Y; Zhang L; Li L Age (Dordr); 2015 Aug; 37(4):9811. PubMed ID: 26169945 [TBL] [Abstract][Full Text] [Related]
2. Icariin Inhibits Overexpression and Aggregation of α-Synuclein in A53T α-Synuclein Transgenic Mice by Regulating Parkin and PLK2. Ma D; Shen C; Zhang X; Zhang L; Li L J Integr Neurosci; 2023 Nov; 22(6):166. PubMed ID: 38176950 [TBL] [Abstract][Full Text] [Related]
3. Tetrahydroxystilbene glucoside antagonizes age-related α-synuclein overexpression in the hippocampus of APP transgenic mouse model of Alzheimer's disease. Zhang L; Yu S; Zhang R; Xing Y; Li Y; Li L Restor Neurol Neurosci; 2013; 31(1):41-52. PubMed ID: 23160059 [TBL] [Abstract][Full Text] [Related]
4. Expression of alpha-synuclein, parkin, and ubiquitin carboxy-terminal hydrolase L1 mRNA in human brain: genes associated with familial Parkinson's disease. Solano SM; Miller DW; Augood SJ; Young AB; Penney JB Ann Neurol; 2000 Feb; 47(2):201-10. PubMed ID: 10665491 [TBL] [Abstract][Full Text] [Related]
5. Involvement of ubiquitin-proteasome system in icariin-induced cardiomyocyte differentiation of embryonic stem cells using two-dimensional gel electrophoresis. Zhu DY; Cui R; Zhang YY; Li H; Zhou LM; Lou YJ J Cell Biochem; 2011 Nov; 112(11):3343-53. PubMed ID: 21751238 [TBL] [Abstract][Full Text] [Related]
6. Differential effects of UCHL1 modulation on alpha-synuclein in PD-like models of alpha-synucleinopathy. Cartier AE; Ubhi K; Spencer B; Vazquez-Roque RA; Kosberg KA; Fourgeaud L; Kanayson P; Patrick C; Rockenstein E; Patrick GN; Masliah E PLoS One; 2012; 7(4):e34713. PubMed ID: 22514658 [TBL] [Abstract][Full Text] [Related]
7. Effects of titanium dioxide nanoparticles on α-synuclein aggregation and the ubiquitin-proteasome system in dopaminergic neurons. Wu J; Xie H Artif Cells Nanomed Biotechnol; 2016; 44(2):690-4. PubMed ID: 25386730 [TBL] [Abstract][Full Text] [Related]
8. [Impacts of electroacupuncture on ubiquitin-proteasome system in rats with Parkinson's disease]. Wang YC; He F; Ma J; Zhou D; Liang Y; Gong YX Zhongguo Zhen Jiu; 2013 Aug; 33(8):725-9. PubMed ID: 24195216 [TBL] [Abstract][Full Text] [Related]
9. Membrane-associated farnesylated UCH-L1 promotes alpha-synuclein neurotoxicity and is a therapeutic target for Parkinson's disease. Liu Z; Meray RK; Grammatopoulos TN; Fredenburg RA; Cookson MR; Liu Y; Logan T; Lansbury PT Proc Natl Acad Sci U S A; 2009 Mar; 106(12):4635-40. PubMed ID: 19261853 [TBL] [Abstract][Full Text] [Related]
10. Aberrant interaction between Parkinson disease-associated mutant UCH-L1 and the lysosomal receptor for chaperone-mediated autophagy. Kabuta T; Furuta A; Aoki S; Furuta K; Wada K J Biol Chem; 2008 Aug; 283(35):23731-8. PubMed ID: 18550537 [TBL] [Abstract][Full Text] [Related]
11. Expression in the mammalian retina of parkin and UCH-L1, two components of the ubiquitin-proteasome system. Esteve-Rudd J; Campello L; Herrero MT; Cuenca N; Martín-Nieto J Brain Res; 2010 Sep; 1352():70-82. PubMed ID: 20638372 [TBL] [Abstract][Full Text] [Related]
12. Parkin-mediated K63-polyubiquitination targets ubiquitin C-terminal hydrolase L1 for degradation by the autophagy-lysosome system. McKeon JE; Sha D; Li L; Chin LS Cell Mol Life Sci; 2015 May; 72(9):1811-24. PubMed ID: 25403879 [TBL] [Abstract][Full Text] [Related]
13. Role of autophagy and proteasome degradation pathways in apoptosis of PC12 cells overexpressing human alpha-synuclein. Yang F; Yang YP; Mao CJ; Cao BY; Cai ZL; Shi JJ; Huang JZ; Zhang P; Liu CF Neurosci Lett; 2009 May; 454(3):203-8. PubMed ID: 19429084 [TBL] [Abstract][Full Text] [Related]
14. Analysis of alpha-synuclein, parkin, tau, and UCH-L1 in a Japanese family with autosomal dominant parkinsonism. Hasegawa K; Funayama M; Matsuura N; Furusawa H; Sakai F; Kowa H; Obata F Eur Neurol; 2001; 46(1):20-4. PubMed ID: 11455179 [TBL] [Abstract][Full Text] [Related]
15. Excess α-synuclein worsens disease in mice lacking ubiquitin carboxy-terminal hydrolase L1. Shimshek DR; Schweizer T; Schmid P; van der Putten PH Sci Rep; 2012; 2():262. PubMed ID: 22355774 [TBL] [Abstract][Full Text] [Related]
16. Potentiation of ATP-induced currents due to the activation of P2X receptors by ubiquitin carboxy-terminal hydrolase L1. Manago Y; Kanahori Y; Shimada A; Sato A; Amano T; Sato-Sano Y; Setsuie R; Sakurai M; Aoki S; Wang YL; Osaka H; Wada K; Noda M J Neurochem; 2005 Mar; 92(5):1061-72. PubMed ID: 15715657 [TBL] [Abstract][Full Text] [Related]
17. Alpha-synuclein and parkin contribute to the assembly of ubiquitin lysine 63-linked multiubiquitin chains. Doss-Pepe EW; Chen L; Madura K J Biol Chem; 2005 Apr; 280(17):16619-24. PubMed ID: 15718234 [TBL] [Abstract][Full Text] [Related]
18. [Parkinson's disease: what have we learned from the genes responsible for familial forms?]. Corti O; Brice A Med Sci (Paris); 2003 May; 19(5):613-9. PubMed ID: 12836396 [TBL] [Abstract][Full Text] [Related]